Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2004-11-13
2010-06-15
Ouspenski, Ilia (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
Reexamination Certificate
active
07737260
ABSTRACT:
Disclosed are a protein conjugate with improved in vivo duration and stability and the use thereof. The protein conjugate includes a physiologically active polypeptide, a non-peptide polymer and an immunoglobulin Fc fragment. Since the three components are covalently linked, the protein conjugate has extended in vivo duration and enhanced stability for the physiologically active polypeptide. The protein conjugate maintains the in vivo activity at relatively high levels and remarkably increases the serum half-life for the physiologically active polypeptide, with less risk of inducing undesirable immune responses. Thus, the protein conjugate is useful for developing long-acting formulations of various polypeptide drugs.
REFERENCES:
patent: 5045312 (1991-09-01), Aston et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5225538 (1993-07-01), Capon et al.
patent: 5349053 (1994-09-01), Landolfi
patent: 5428130 (1995-06-01), Capon et al.
patent: 5447851 (1995-09-01), Beutler et al.
patent: 5455165 (1995-10-01), Capon et al.
patent: 5514582 (1996-05-01), Capon et al.
patent: 5585097 (1996-12-01), Bolt et al.
patent: 5605690 (1997-02-01), Jacobs et al.
patent: 5650150 (1997-07-01), Gillies
patent: 5672688 (1997-09-01), Kobayashi et al.
patent: 5712121 (1998-01-01), Devos et al.
patent: 5714147 (1998-02-01), Capon et al.
patent: 5723125 (1998-03-01), Chang et al.
patent: 5843725 (1998-12-01), Sledziewski et al.
patent: 5844099 (1998-12-01), Stahl et al.
patent: 5908626 (1999-06-01), Chang et al.
patent: 5977310 (1999-11-01), Namiki et al.
patent: 6018026 (2000-01-01), Sledziewski et al.
patent: 6030613 (2000-02-01), Blumberg et al.
patent: 6117656 (2000-09-01), Seed
patent: 6165476 (2000-12-01), Strom et al.
patent: 6277375 (2001-08-01), Ward
patent: 6291212 (2001-09-01), Sledziewski et al.
patent: 6291646 (2001-09-01), Sledziewski et al.
patent: 6300099 (2001-10-01), Sledziewski et al.
patent: 6307025 (2001-10-01), Hession et al.
patent: 6323323 (2001-11-01), Sledziewski et al.
patent: 6340742 (2002-01-01), Burg et al.
patent: 6406697 (2002-06-01), Capon et al.
patent: 6410008 (2002-06-01), Strom et al.
patent: 6441136 (2002-08-01), Pettit
patent: 6444792 (2002-09-01), Gray et al.
patent: 6451313 (2002-09-01), Maddon et al.
patent: 6475983 (2002-11-01), Eid et al.
patent: 6482919 (2002-11-01), Ledbetter et al.
patent: 6541610 (2003-04-01), Smith
patent: 6620413 (2003-09-01), DeSauvage et al.
patent: 6656728 (2003-12-01), Kavanaught et al.
patent: 6660843 (2003-12-01), Feige et al.
patent: 6677136 (2004-01-01), Marshall et al.
patent: 6743778 (2004-06-01), Kohno
patent: 6756480 (2004-06-01), Kostenuik et al.
patent: 7125843 (2006-10-01), DeFrees et al.
patent: 2001/0053539 (2001-12-01), Lauffer et al.
patent: 2002/0037558 (2002-03-01), Lo et al.
patent: 2002/0081664 (2002-06-01), Lo et al.
patent: 2003/0073164 (2003-04-01), Simmons et al.
patent: 2003/0082679 (2003-05-01), Sun et al.
patent: 2003/0082749 (2003-05-01), Sun et al.
patent: 2003/0229023 (2003-12-01), Oliner et al.
patent: 2004/0044188 (2004-03-01), Feige et al.
patent: 2004/0053845 (2004-03-01), Feige et al.
patent: 2004/0181033 (2004-09-01), Han et al.
patent: 2005/0163799 (2005-07-01), Mann et al.
patent: 2006/0275254 (2006-12-01), Kim et al.
patent: 0 464 533 (1992-01-01), None
patent: 0 580 171 (1994-01-01), None
patent: 62-201582 (1987-09-01), None
patent: 10-0249572 (1999-12-01), None
patent: 10-0316347 (2001-11-01), None
patent: 2003-0009464 (2003-01-01), None
patent: 90/04413 (1990-05-01), None
patent: 91/16354 (1991-10-01), None
patent: 92/10507 (1992-06-01), None
patent: 97/00319 (1997-01-01), None
patent: 97/24137 (1997-07-01), None
patent: 99/02709 (1999-01-01), None
patent: 00/23472 (2000-04-01), None
patent: 00/40615 (2000-07-01), None
patent: 00/69913 (2000-11-01), None
patent: 01/03737 (2001-01-01), None
patent: 01/83527 (2001-11-01), None
patent: 02/46227 (2002-06-01), None
patent: 03/076567 (2003-09-01), None
patent: 03/077834 (2003-09-01), None
patent: 2004/101739 (2004-11-01), None
patent: 2004/101740 (2004-11-01), None
patent: 2004/108885 (2004-12-01), None
patent: 2005/001025 (2005-01-01), None
patent: 2005/017148 (2005-02-01), None
patent: 2005/037989 (2005-04-01), None
patent: 2005/073383 (2005-08-01), None
Bentz et al., “Improved local delivery of TGF-β2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol,”J. Biomed. Mat. Res. 39(4):539-548, 1998.
Champman, “PEGylated antibodies and antibody fragments for improved therapy: A review.”Advanced Drug Delivery Reviews54(4):531-545, Jun. 17, 2002.
Matsuda et al., “Proton nuclear magnetic resonance studies of the structure of the Fc fragment of human immunoglobulin G1: comparisons of native and recombinant proteins,”Molecular Immunology27(6):571-580, 1990.
Stevenson et al. “Conjugation of human Fcγ in closed-hinge or open-hinge configuration to Fab'γ and analogous ligands,”Journal of Immunology158:2242-2250, Jan. 1, 1997.
van der Poll et al., “Effect of a Recombinant Dimeric Tumor Necrosis Factor Receptor on Inflammatory Responses to Intravenous Endotoxin in Normal Humans,”Blood89(10):3727-3734, May 15, 1997.
Bae Sung Min
Kim Dae Jin
Kim Young Min
Kwon Se Chang
Lee Gwan Sun
Hanmi Pharm. Co., Ltd
Ouspenski Ilia
Sughrue & Mion, PLLC
LandOfFree
Protein complex using an immunoglobulin fragment and method... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein complex using an immunoglobulin fragment and method..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein complex using an immunoglobulin fragment and method... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4200819